Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A

Neuroscience, 2011 - Elsevier
Abstract Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic
hyperactivity disorders, and, recently, migraine headache. Although suggested to act only …
被引用次数：218 相关文章

[引用][C] Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A

I MATAK - Neuroscience, 2011 - cir.nii.ac.jp

Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A

I Matak, L Bach-Rojecky, B Filipović, Z Lacković - Neuroscience, 2011 - medlib.mef.hr
Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic hyperactivity
disorders, and, recently, migraine headache. Although suggested to act only locally, novel …

Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A

I Matak, L Bach-Rojecky, B Filipović… - …, 2011 - ibroneuroscience.org
Abstract Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic
hyperactivity disorders, and, recently, migraine headache. Although suggested to act only …

Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A

I Matak, L Bach-Rojecky, B Filipović, Z Lacković - Neuroscience, 2011 - infona.pl
Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic hyperactivity
disorders, and, recently, migraine headache. Although suggested to act only locally, novel …

[引用][C] BEHAVIORAL AND IMMUNOHISTOCHEMICAL EVIDENCE FOR CENTRAL ANTINOCICEPTIVE ACTIVITY OF BOTULINUM TOXIN A

I MATAK, L BACH-ROJECKY, B FILIPOVIC… - …, 2011 - pascal-francis.inist.fr
BEHAVIORAL AND IMMUNOHISTOCHEMICAL EVIDENCE FOR CENTRAL
ANTINOCICEPTIVE ACTIVITY OF BOTULINUM TOXIN A CNRS Inist Pascal-Francis CNRS …

Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A

I Matak, L Bach-Rojecky, B Filipović, Z Lacković - Neuroscience, 2011 - croris.hr
Sažetak Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic
hyperactivity disorders, and, recently, migraine headache. Although suggested to act only …

Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A.

I Matak, L Bach-Rojecky, B Filipović, Z Lacković - Neuroscience, 2011 - europepmc.org
Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic hyperactivity
disorders, and, recently, migraine headache. Although suggested to act only locally, novel …

Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A

I Matak, L Bach-Rojecky, B Filipović, Z Lacković - Neuroscience, 2011 - hero.epa.gov
Abstract Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic
hyperactivity disorders, and, recently, migraine headache. Although suggested to act only …

Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A

I Matak, L Bach-Rojecky, B Filipović… - …, 2011 - pubmed.ncbi.nlm.nih.gov
Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic hyperactivity
disorders, and, recently, migraine headache. Although suggested to act only locally, novel …